Skip to content
Open access

Clinical Experience With the Use of a 675 nm Laser System With a Faster Treatment Strategy for Melasma in Indian Patients

Oct 2026 · Aesthetic Surgery Journal Open Forum · 0 citations

Abstract

Melasma is a commonly acquired hyperpigmentation disorder. This is a retrospective, clinical study conducted to evaluate the use of 675-nm wavelength laser treatment in Indian patients affected by facial melasma. A total of 52 patients with clinically diagnosed melasma were treated with a 675-nm laser system. All participants underwent four treatment sessions, each performed at 27 ± 7-day intervals. Patient’s pigment reduction and skin homogeneity were assessed with photographic documentation and with the use of the modified Melasma Area and Severity Index (mMASI) at baseline, and 3-month follow up after the last laser treatment. In addition, patients’ satisfaction scores were evaluated. mMASI score significantly decreased from 3.8 ± 2.3 at baseline to 2.8 ± 1.7 after treatment. The photographic assessment was consistent with a reduction in pigmentation following treatment. Concerning patient satisfaction scores, 13% of participants reported not being satisfied, 29% were slightly satisfied, 32% were moderately satisfied, and 26% were very satisfied with the overall treatment outcome. There were no major adverse effects reported during the treatment period. The application of the 675-nm laser was associated with short-term improvement to reduce pigmentary symptoms associated with facial melasma in both Indian men and women. However, the retrospective design, absence of a control group, and relatively short follow-up period limit the strength of these findings. Further prospective controlled studies with longer follow-up are needed to confirm efficacy and durability of results.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.